4-butyrolactone has been researched along with Acute Lung Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HB; Xiao, YG; Yang, Y; Zhong, ZT | 1 |
| Dai, J; Huang, J; Jiang, R; Tang, L; Tian, R; Yang, Y; Zhang, L | 1 |
| Scheper, H; Touw, DJ; van Gerwen, M; van Nieuwkoop, C | 1 |
3 other study(ies) available for 4-butyrolactone and Acute Lung Injury
| Article | Year |
|---|---|
The Activation of AMPK/NRF2 Pathway in Lung Epithelial Cells Is Involved in the Protective Effects of Kinsenoside on Lipopolysaccharide-Induced Acute Lung Injury.
Topics: 4-Butyrolactone; Acute Lung Injury; AMP-Activated Protein Kinases; Animals; Epithelial Cells; Lipopolysaccharides; Lung; Mice; Monosaccharides; NF-E2-Related Factor 2 | 2022 |
The SIRT1 inhibitor EX-527 suppresses mTOR activation and alleviates acute lung injury in mice with endotoxiemia.
Topics: 4-Butyrolactone; Acute Lung Injury; Adaptor Proteins, Signal Transducing; Animals; Carbazoles; Carrier Proteins; Cell Cycle Proteins; Endotoxemia; Eukaryotic Initiation Factors; Interleukin-6; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Phosphoproteins; Phosphorylation; Plasminogen Activator Inhibitor 1; Sirtuin 1; Thromboplastin; TOR Serine-Threonine Kinases; Tumor Necrosis Factor-alpha | 2017 |
Life-threatening acute lung injury after gamma butyrolactone ingestion.
Topics: 4-Butyrolactone; Acute Lung Injury; Adult; Deglutition; Female; Humans; Solvents; Tomography, X-Ray Computed | 2015 |